Gene Therapy Market Research Report Information By Product Type (Kymriah, Luxturna, Yescarta, Zolgensma, Zynteglo), By Indication (Oncology And Genetic Diseases), By End Users(Hospitals & Clinics, Specialty Treatment Centers), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Gene Therapy Market, by Product

6.1 Introduction

6.2 Kymriah

6.3 Luxturna

6.4 Yescarta

6.5 Zolgensma

6.6 Strimvelis

6.7 Zynteglo

6.8 Imlygic

6.9 Others

Chapter 7. Global Gene Therapy Market, by Indication

7.1 Introduction

7.2 Oncology

7.2.1 B-cell Acute Lymphoblastic Leukemia (ALL)

7.2.2 B-Cell Lymphoma

7.2.3 Others

7.3 Genetic Diseases/ Disorders

7.3.1 Retinal Dystrophy

7.3.2 Spinal Muscular Atrophy (SMA)

7.3.3 β-thalassemia

7.3.4 ADA-SCID

7.3.5 Familial Lipoprotein Lipase Deficiency (LPLD)

7.4 Others

Chapter 8. Global Gene Therapy Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

8.3 Specialty Treatment Centers

8.4 Others

Chapter 9. Global Gene Therapy Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

Chapter 10. Competitive Landscape

10.1 Overview

10.2 Competitive Analysis

10.3 Market Share Analysis

10.4 Major Growth Strategy in the global cough & cold treatment market

10.5 Competitive Benchmarking

10.6 Leading Player in terms of Number of Developments in global cough & cold treatment market

10.7 Key Developments & Growth Strategies

10.7.1 New Product Launch/Service Deployment

10.7.2 Merger & Acquisition

10.7.3 Joint Ventures

10.8 Major Players Financial Matrix & Market Ratio

10.8.1 Sales & Operating Income 2020

10.8.2 Major Players R&D Expenditure 2020

12.8.3 Major Players Capital Market Ratio

Chapter 11 Company Profiles

11.1 Amgen, Inc.

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Treatments Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2 Novartis AG

11.2.1 Company Overview

11.2.2 Financial Overview

11.2.3 Treatments Offered

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.2.6 Key Strategies

11.3 Spark Therapeutics, Inc.

11.3.1 Company Overview

11.3.2 Financial Overview

11.3.3 Treatments Offered

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.3.6 Key Strategies

11.4 Gilead Sciences, Inc.

11.4.1 Company Overview

11.4.2 Financial Overview

11.4.3 Treatments Offered

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.4.5 Key Strategies

11.5 uniQure N.V.

11.5.1 Company Overview

11.5.2 Financial Overview

11.5.3 Treatments Offered

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.5.6 Key Strategies

11.6 Orchard Therapeutics plc

11.6.1 Company Overview

11.6.2 Financial Overview

11.6.3 Treatments Offered

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.6.6 Key Strategies

11.7 Celgene Corporation

11.7.1 Company Overview

11.7.2 Financial Overview

11.7.3 Treatments Offered

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.7.6 Key Strategies

11.8 Bristol-Myers Squibb Company

11.8.1 Company Overview

11.8.2 Financial Overview

11.8.3 Treatments Offered

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.8.6 Key Strategies

11.9 Thermo Fisher Scientific Inc.

11.9.1 Company Overview

11.9.2 Financial Overview

11.9.3 Treatments Offered

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.9.6 Key Strategies

11.10 CEVEC

11.10.1 Company Overview

11.10.2 Financial Overview

11.10.3 Treatments Offered

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.10.6 Key Strategies

11.11 Lonza

11.11.1 Company Overview

11.11.2 Financial Overview

11.11.3 Treatments Offered

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.11.5 Key Strategies

11.11 Others

11.11.1 Company Overview

11.11.2 Financial Overview

11.11.3 Treatments Offered

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.11.6 Key Strategies

Chapter 12. Appendix

12.1. References

12.2. Related Reports

LIST OF TABLES

Table 1 Global Gene Therapy Synopsis, 2020-2027

Table 2 Global Gene Therapy Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Gene Therapy Market, by Region, 2020-2027(USD Million)

Table 4 Global Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 5 Global Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 6 Global Gene Therapy Market, by End User, 2020-2027(USD Million)

Table 7 Americas: Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 8 Americas: Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 9 Americas: Gene Therapy Market, by End User, 2020-2027(USD Million)

Table 10 Americas: Gene Therapy Market, by Region, 2020-2027(USD Million)

Table 11 North America: Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 12 North America: Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 13 North America: Gene Therapy Market, by End User, 2020-2027(USD Million)

Table 14 Latin America: Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 15 Latin America: Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 16 Latin America: Gene Therapy Market, by End User, 2020-2027(USD Million)

Table 17 Europe: Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 18 Europe: Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 19 Europe: Gene Therapy Market, by End User, 2020-2027(USD Million)

Table 20 Europe: Gene Therapy Market, by Region, 2020-2027(USD Million)

Table 21 Western Europe: Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 22 Western Europe: Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 23 Western Europe: Gene Therapy Market, by End User, 2020-2027(USD Million)

Table 24 Eastern Europe: Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 25 Eastern Europe: Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 26 Eastern Europe: Gene Therapy Market, by End User, 2020-2027(USD Million)

Table 27 Asia-Pacific: Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 28 Asia-Pacific: Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 29 Asia-Pacific: Gene Therapy Market, by End User, 2020-2027(USD Million)

Table 30 Middle East & Africa: Gene Therapy Market, by Product, 2020-2027(USD Million)

Table 31 Middle East & Africa: Gene Therapy Market, by Indication, 2020-2027(USD Million)

Table 32 Middle East & Africa: Gene Therapy Market, by End User, 2020-2027(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation of the Global Gene Therapy Market

Figure 3 Market Dynamics for the Global Gene Therapy Market

Figure 4 Global Gene Therapy Market Share, by Product, 2020

Figure 5 Global Gene Therapy Market Share, by Indication, 2020

Figure 6 Global Gene Therapy Market Share, by End User, 2020

Figure 7 Global Gene Therapy Market Share, by Region, 2020

Figure 8 Americas: Gene Therapy Market Share, by Region, 2020

Figure 9 North America: Gene Therapy Market Share, by Country, 2020

Figure 10 Latin America: Gene Therapy Market Share, by Country, 2020

Figure 11 Europe: Gene Therapy Market Share, by Country, 2020

Figure 12 Asia-Pacific: Gene Therapy Market Share, by Country, 2020

Figure 13 Middle East & Africa: Gene Therapy Market Share, by Country, 2020

Figure 14 Global Gene Therapy Market: Company Share Analysis, 2020 (%)

Figure 15 Amgen, Inc.: Key Financials

Figure 16 Amgen, Inc.: Segmental Revenue

Figure 17 Amgen, Inc.: Regional Revenue

Figure 18 Novartis AG: Key Financials

Figure 19 Novartis AG: Segmental Revenue

Figure 20 Novartis AG: Regional Revenue

Figure 21 Spark Therapeutics, Inc.: Key Financials

Figure 22 Spark Therapeutics, Inc.: Segmental Revenue

Figure 23 Spark Therapeutics, Inc.: Regional Revenue

Figure 24 Gilead Sciences, Inc.: Key Financials

Figure 25 Gilead Sciences, Inc.: Segmental Revenue

Figure 26 Gilead Sciences, Inc.: Regional Revenue

Figure 27 uniQure N.V.: Key Financials

Figure 28 uniQure N.V.: Regional Revenue

Figure 29 uniQure N.V.: Key Financials

Figure 30 Orchard Therapeutics plc.: Segmental Revenue

Figure 31 Orchard Therapeutics plc.: Regional Revenue

Figure 32 Orchard Therapeutics plc.: Key Financials

Figure 33 Celgene Corporation: Segmental Revenue

Figure 34 Celgene Corporation: Regional Revenue

Figure 35 Celgene Corporation: Key Financials

Figure 36 Bristol-Myers Squibb Company: Segmental Revenue

Figure 37 Bristol-Myers Squibb Company: Regional Revenue

Figure 38 Bristol-Myers Squibb Company: Key Financials

Figure 39 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 40 Thermo Fisher Scientific Inc.: Regional Revenue

Figure 41 Thermo Fisher Scientific Inc.: Key Financials

Figure 42 CEVEC: Segmental Revenue

Figure 43 CEVEC: Regional Revenue

Figure 44 CEVEC: Key Financials

Figure 45 Lonza: Segmental Revenue

Figure 46 Lonza: Regional Revenue

Figure 47 Lonza: Key Financials